Patents Represented by Attorney, Agent or Law Firm Pepper Hamilton LLP
  • Patent number: 8242044
    Abstract: Aromatic or heteroaromatic nitro compounds are catalytically hydrogenated to the corresponding amines in the presence of a platinum catalyst comprising elemental platinum on a support; the platinum catalyst is modified with a molybdenum compound and a phosphorus compound wherein the phosphorus has an oxidation state of less than +5, e.g. hypophosphorous acid; the catalyst is particularly useful in the hydrogenation of nitro compounds with halogen and/or sulfur-containing substituents.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: August 14, 2012
    Assignee: AstraZeneca AB
    Inventors: Wilhelm Quittman, Thomas Peter Belser, Rhony Niklaus Aufdenblatten
  • Patent number: 8236994
    Abstract: The present invention provides a method for the anaerobic production of 1,3 propanediol, by culturing a Clostridium strain in an appropriate culture medium comprising glycerol as a source of carbon, wherein said Clostridium strain does not produce substantially other products of the glycerol metabolism selected among the group consisting of: butyrate, lactate, butanol and ethanol, and recovering of 1,3-propanediol.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: August 7, 2012
    Assignee: Metabolic Explorer
    Inventor: Philippe Soucaille
  • Patent number: 8236302
    Abstract: One aspect of the present invention relates to mutants of chondroitinase ABCI. Such chondroitinase ABCI mutants exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to UV light or heat. Methods of using chondroitinase ABCI mutant enzymes are also provided.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: August 7, 2012
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Anthony O. Caggiano, Jennifer Iaci, Andrea Vecchione, Elizabeth Markensohn
  • Patent number: 8236775
    Abstract: RNA interference using small interfering RNAs which target HIF-1 alpha mRNA inhibit expression of the HIF-1 alpha gene. As HIF-1 alpha is a transcriptional regulator of VEGF, expression of VEGF is also inhibited. Control of VEGF production through siRNA-mediated down-regulation of HIF-1 alpha can be used to inhibit angiogenesis, in particularly in diseases such as diabetic retinopathy, age related macular degeneration and many types of cancer.
    Type: Grant
    Filed: December 3, 2009
    Date of Patent: August 7, 2012
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Samuel Jotham Reich, Enrico Maria Surace, Michael J. Tolentino
  • Patent number: 8232428
    Abstract: Aspects of the present invention relate to compounds and methods useful in modulating angiogenesis and methods of treating or preventing diseases associated with angiogenesis by administering a polycationic compound. The present invention relates to methods of use and compositions for inhibiting angiogenesis-mediated disorders in mammals including animals and humans. Additionally, this invention relates to the combined use of polycations with other anti-angiogenesis agents for the treatment of different angiogenesis-mediated disorders. Additionally, those polycationic compounds can be used with various anti-inflammatory and cytotoxic agents as well as with radio-therapeutic agents in cancer patients to prevent and treat tumor growth and metastasis.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: July 31, 2012
    Assignee: PolyMedix,Inc.
    Inventors: Shaker Mousa, Dahui Liu
  • Patent number: 8231888
    Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein A1, A2, A3, A4, A5 and A6 are independently selected from the group consisting of CR3 and N; provided that at most 3 of A1, A2, A3, A4, A5 and A6 is N; B1, B2 and B3 are independently selected from the group consisting of CR2 and N; each R3 is independently H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylamino, C2-C6 dialkylamino, —CN or —NO2; and R1, R2, R4, R5, W and n are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: July 31, 2012
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: George Philip Lahm, Wesley Lawrence Shoop, Ming Xu
  • Patent number: 8232247
    Abstract: The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: July 31, 2012
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Yin Xu, Qin Yu
  • Patent number: 8233690
    Abstract: A method of dynamically reconstructing three dimensional (3D) tomographic images from a set of projection images is disclosed. The method includes the steps of loading a set of projection images into a memory device, determining a reconstruction method for the set of projection images, reconstructing a 3D tomographic image from the set of projection images to be displayed to a user; and performing any post reconstruction processing on the 3D tomographic image.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: July 31, 2012
    Assignee: Real-Time Tomography, LLC
    Inventors: Susan Ng, Peter A. Ringer
  • Patent number: 8226253
    Abstract: The invention is directed to a system for concentrating light for solar thermal and solar photovoltaic generating systems. The system includes a plurality of concentrating regions. Each concentrating region includes an input end having a perimeter or width in a lenticular configuration, an output end having a perimeter or width in a lenticular configuration, and a portion located therebetween defined by a reflective boundary. The invention is also directed to a method of manufacturing a light collection system. The method includes forming a film having multiple recesses. Each recess includes an input end, an output end and a reflective boundary. The output end has a smaller perimeter or a width in a lenticular configuration than a perimeter or a width of the input end in the lenticular configuration.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: July 24, 2012
    Inventors: Neil D. Lubart, Thomas E. Lash, Timothy J. Wojciechowski
  • Patent number: 8227444
    Abstract: Disclosed herein are siRNA compositions and methods useful for inhibiting expression of vascular endothelial growth factor (VEGF) isoforms. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering small interfering RNAs as disclosed.
    Type: Grant
    Filed: December 6, 2010
    Date of Patent: July 24, 2012
    Assignee: Opko Ophthalmics, LLC
    Inventor: Nadine Dejneka
  • Patent number: 8226941
    Abstract: An aspect of the present invention relates to stable formulations of chondroitinase and to methods of purifying chondroitinase. The methods of purifying chondroitinase includes the steps of extracting the enzyme from a cell, separating the chondroitinase from the crude cell extract using cation-exchange chromatography, removing impurities through gel filtration chromatography, and removing endotoxin through an anion-exchange membrane to produce a purified chondroitinase.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: July 24, 2012
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Anthony O. Caggiano, Elliott A. Gruskin, Yelena G. Sheptovitsky, Sarah Kasperbauer
  • Patent number: 8222211
    Abstract: A novel class of embryo derived peptides are described (Preimplantation factor) that were generated synthetically and were tested on peripheral blood immune cells and shown to block activated but not basal immunity, inhibiting cell proliferation and creating a TH2 type cytokine bias. In addition PIF peptides enhance endometrial receptivity by increasing adhesion molecules expression. PIF biological activity appears to be exerted by specific binding to inducible receptors present on the several white cell lineages. PIF peptides, which are immune modulators, therefore may have diagnostic and non toxic therapeutic applications in improving fertility, reducing pregnancy loss as well may be useful when administered for the treatment of autoimmune diseases and for prevention xenotransplants rejection.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: July 17, 2012
    Assignee: BioIncept, LLC
    Inventor: Eytan R. Barnea
  • Patent number: 8220611
    Abstract: A system is disclosed for mounting currency mechanisms of various sizes and shapes in vending machines or the like. The system may allow for relatively simple installation and removal of currency mechanisms without the use of mounting screws. The system includes a mounting surface, a portion of which is adapted to mate with a first surface of a currency mechanism. A tab is extended from the mounting surface to engage an opening in the first surface of the currency mechanism. A retention device is coupled to the mounting surface and is manipulable to engage a second surface of the currency mechanism and to cooperate with the tab to grip the currency mechanism.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: July 17, 2012
    Assignee: MEI, Inc.
    Inventor: Evan J. Cost
  • Patent number: 8221452
    Abstract: Systems and methods introduce a closure material to seal a vessel puncture site. The system and methods provide a catheter adapted for passage through a tissue puncture and sized to occupy substantially all the tissue puncture. The catheter includes a lumen in fluid communication with a fluid delivery port adjacent the catheter distal end. One or more dispensers are in fluid communication with the catheter lumen for dispensing first and second fluid compositions in the catheter lumen. An actuator causes the first and second fluid compositions to be dispensed from the dispensers and mixed by flowing the first and second fluid compositions through a static mixer. The first and second fluid compositions are dispensed from the fluid delivery port as a fluid mixture that reacts in situ to form a nonfluent closure composition adjacent the vessel puncture site.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: July 17, 2012
    Assignee: Neomend, Inc.
    Inventors: Stuart D. Edwards, Ronald Lax, Theodore L. Parker, Thomas C. Wehman, Theodore Kucklick, Eugene Skalnyi
  • Patent number: 8221736
    Abstract: cis-Jasmone has been discovered to be useful as a semiochemical that changes the behavior of insects and/or the physiology of plants. It has direct signalling roles with plant-feeding aphids, in attraction of aphid predators and parasitoids, and may act as an airborne signal inducing production of volatile plant semiochemicals, including the monoterpene (E)-?-ocimene, that stimulate foraging by parasitoids. It is an extremely benign compound having, to human beings, a pleasant aroma and gives a long-lasting effect after removal of the stimulus.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: July 17, 2012
    Assignee: Rothamsted Research Limited
    Inventors: Alastair James Hick, John Anthony Pickett, Lester John Wadhams, Johnathan Andrew Napier
  • Patent number: 8221711
    Abstract: Compositions and methods for removing mercury and/or cadmium from samples containing mercury and/or cadmium or thought to contain mercury and/or cadmium are described. Selenium core-sheath compositions containing a selenium nanostructure core and a melt-resistant sheath can be used to remove mercury and/or cadmium from high-temperature environments.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: July 17, 2012
    Assignee: Empire Technology Development LLC
    Inventor: Kwangyeol Lee
  • Patent number: 8217180
    Abstract: Disclosed is a method for preparing a compound of Formula 1 wherein R1 is CHX2, CX3, CX2CHX2 or CX2CX3; each X is independently Cl or F; Z is optionally substituted phenyl; and Q is phenyl or 1-naphthalenyl, each optionally substituted as defined in the disclosure; comprising contacting a compound of Formula 2 with hydroxylamine in the presence of a base. The present invention also relates to novel compounds of Formula 2, useful as starting materials for the aforedescribed method.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: July 10, 2012
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Gary David Annis, Brenton Todd Smith
  • Patent number: 8216535
    Abstract: Methods and systems for reducing mercury emissions from fluid streams having a high concentration of sulfur oxide species are provided herein. In embodiments, mercury is removed from flue gas streams containing sulfur trioxide (SO3) by injecting a dry admixture of a porous mercury adsorptive material and at least one dry agent into the flue gas stream.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: July 10, 2012
    Assignee: Calgon Carbon Corporation
    Inventors: Nicholas R. Pollack, Richard A. Hayden
  • Patent number: 8216585
    Abstract: Drug delivery compositions and methods of delivering compounds into a cell or into an individual are disclosed. Vaccines and methods of immunizing individuals are disclosed. Compositions for drug delivery including gene therapy and methods of treating individuals using such compositions are disclosed.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: July 10, 2012
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: David B. Weiner, Karuppiah Muthumani, Donghui Zhang, Mathura P. Ramanathan
  • Patent number: 8210435
    Abstract: An apparatus for marking predetermined known overhead positional locations within a coordinate space, for viewing by an image acquisition system. The apparatus comprises a plurality of marker tags, grouped in one or more rows, each row having an axis, each row being supported by a row support. Each marker tag comprises an optically opaque, dark colored corrugated substrate, substantially rectangular in shape. A label having a unique machine-readable barcode symbology printed thereon is positioned centrally on the substrate so that a dark colored border of the substrate surrounds the label. Each row support comprises a first support cord and a second support cord. The first support cord supports a first lateral edge of the marker tags in a row group in a fixed, spaced-apart positional arrangement. The second support cord supports the second lateral edge of the marker tags in the row in a slidable support arrangement.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: July 3, 2012
    Assignee: Sky-Trax, Inc.
    Inventors: Larry G. Mahan, Sarah M. Brisbin, Kimberly M. Martine